Literature DB >> 19822851

Complement factor H and the bilaterality of age-related macular degeneration.

Amy Shih-I Pai1, Paul Mitchell, Elena Rochtchina, Sudha Iyengar, Jie Jin Wang.   

Abstract

OBJECTIVE: To determine whether complement factor H (CFH Y402H) genotype influences bilateral involvement of age-related macular degeneration (AMD) lesions.
METHODS: The Blue Mountains Eye Study (BMES) followed up 3654 participants 49 years and older (BMES 1, 1992-1994), including 2335 (75.3% of survivors) at the 5-year (BMES 2, 1997-1999) and 1952 (76.5%) at the 10-year (BMES 3, 2002-2004) examinations. Age-related macular degeneration retinal photographic grading used the Wisconsin system. Early and late AMD included prevalent and incident cases from all visits. CFH genotyping used TaqMan assays.
RESULTS: Of 767 AMD cases, 53.3% of early and 53.1% of late AMD cases were bilateral. After adjusting for age and other covariants, the CFH CC (Y402H polymorphism) genotype was associated with an increased likelihood of bilateral compared with unilateral involvement by any soft drusen (odds ratio [OR], 2.5; 95% confidence interval [CI], 1.4-4.5), distinct soft drusen (OR, 2.8; 95% CI, 1.0-8.1), and pigmentary abnormalities (OR, 1.7; 95% CI, 1.0-2.8). We could not establish significant associations between this genotype and the bilaterality of late AMD (OR, 1.8; 95% CI, 0.4-7.7), either geographic atrophy (OR, 0.6; 95% CI, 0.07-4.6) or neovascular AMD (OR, 3.4; 95% CI, 0.3-41.4).
CONCLUSIONS: Persons with the CFH CC genotype at any given age have an increased likelihood of bilateral compared with unilateral involvement of some early AMD lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822851     DOI: 10.1001/archophthalmol.2009.239

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors.

Authors:  Yuhong Chen; Jiexi Zeng; Chao Zhao; Kevin Wang; Elizabeth Trood; Jeanette Buehler; Matthew Weed; Daniel Kasuga; Paul S Bernstein; Guy Hughes; Victoria Fu; Jessica Chin; Clara Lee; Maureen Crocker; Matthew Bedell; Francesca Salasar; Zhenglin Yang; Michael Goldbaum; Henry Ferreyra; William R Freeman; Igor Kozak; Kang Zhang
Journal:  Arch Ophthalmol       Date:  2011-03

2.  The ARMS2 A69S variant and bilateral advanced age-related macular degeneration.

Authors:  Stephen G Schwartz; Anita Agarwal; Jaclyn L Kovach; Paul J Gallins; William Cade; Eric A Postel; Gaofeng Wang; Juan Ayala-Haedo; Kylee M Spencer; Jonathan L Haines; Margaret A Pericak-Vance; William K Scott
Journal:  Retina       Date:  2012-09       Impact factor: 4.256

3.  Complement factor H and LOC387715/ARMS2/HTRA1 variant's frequencies and phenotypic associations in neovascular age-related macular degeneration, a pilot study.

Authors:  Reza Karkhane; Aliasghar Ahmadraji; Mohammad Riazi Esfahani; Ramak Roohipour; Zahra Alami Harandi; Alireza Lashay; Mehdi Sharifzadeh Kermani; Reza Roozafzoon; Ahad Khoshzaban
Journal:  J Curr Ophthalmol       Date:  2016-03-08

4.  A genome-wide association study identified a novel genetic loci STON1-GTF2A1L/LHCGR/FSHR for bilaterality of neovascular age-related macular degeneration.

Authors:  Kyoko Kawashima-Kumagai; Kenji Yamashiro; Munemitsu Yoshikawa; Masahiro Miyake; Gemmy Cheung Chui Ming; Qiao Fan; Jia Yu Koh; Masaaki Saito; Masako Sugahara-Kuroda; Maho Oishi; Yumiko Akagi-Kurashige; Isao Nakata; Hideo Nakanishi; Norimoto Gotoh; Akio Oishi; Hiroshi Tamura; Sotaro Ooto; Akitaka Tsujikawa; Yasuo Kurimoto; Tetsuju Sekiryu; Fumihiko Matsuda; Chiea-Chuen Khor; Ching-Yu Cheng; Tien Yin Wong; Nagahisa Yoshimura
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.